Myriad Genetics (MYGN)

Add to Watchlists
Create an Alert
40.08 +0.40  +1.01% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
MYGN Price Chart
View All Events

MYGN Events

Date Type Description
May 06 Misc Q3 2014 Myriad Genetics Inc Earnings Conference Call
May 06 Earnings Q3 2014 Myriad Genetics Inc Earnings Results. Estimate: 0.46.
Feb 04 Misc Myriad Genetics, Inc. 2Q2014 Earning Conference Call
Feb 04 Earnings Myriad Genetics, Inc. 2Q2014 Earning Result. Estimate: 0.47.
Dec 12 Misc Myriad Genetics Announces Upcoming Investor Event
Dec 05 Misc AGM Event for Myriad Genetics, Inc.
Nov 05 Misc Myriad Genetics to Announce Fiscal First Quarter 2014 Financial Results Conference Call
Nov 05 Earnings Myriad Genetics to Announce Fiscal First Quarter 2014 Financial Results on Tuesday November 5, 2013. Estimate: 0.46.
Aug 13 Misc Myriad Genetics Announces Date of Full-year and Fourth-quarter Fiscal 2013 Financial Results Conference Call
Aug 13 Earnings Myriad Genetics Announces Fourth-Quarter Fiscal 2013 Financial Results. Estimate: 0.43.
View All Performance Charts

MYGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myriad Genetics is up 42.84% over the last year vs S&P 500 Total Return up 21.54%, Actelion up 67.22%, and ANI Pharmaceuticals up 370.3%.

Get Quote for

PDF Report for MYGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MYGN Pro Report PDF

Portfolio Strategies Featuring MYGN

Did Myriad Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MYGN Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: Utah
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Myriad Genetics, Inc. is a molecular diagnostic company based in Salt Lake City, Utah. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy and tailor a patient's drug dose to ensure optimal treatment (personalized medicine), and assess a patient's risk of disease progression and disease recurrence (prognostic medicine). The company was founded in May 1991 and is headquartered in Salt Lake City, Utah.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MYGN 40.08 +0.40 +1.01% 2.925B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.